These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10396111)

  • 1. [Terlipressin in the treatment of portal hypertension].
    Primo J; Molés JR; Fernández J; Llorca P; Hinojosa J
    Gastroenterol Hepatol; 1999 May; 22(5):258-60. PubMed ID: 10396111
    [No Abstract]   [Full Text] [Related]  

  • 2. [Terlipressin in the treatment of portal hypertension].
    Escorsell A; Bosch J
    Gastroenterol Hepatol; 1998 Nov; 21(9):452-8. PubMed ID: 9882938
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug therapy for portal hypertension.
    Lebrec D
    Gut; 2001 Sep; 49(3):441-2. PubMed ID: 11511569
    [No Abstract]   [Full Text] [Related]  

  • 4. Significant improvement of portopulmonary hypertension after 1-week terlipressin treatment.
    Kalambokis G; Korantzopoulos P; Nikas SA; Theodorou A; Tsianos EV
    J Hepatol; 2008 Apr; 48(4):678-80. PubMed ID: 18280605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin analogs in portal hypertension: different molecules but similar questions.
    Blei AT
    Hepatology; 1986; 6(1):146-7. PubMed ID: 3510949
    [No Abstract]   [Full Text] [Related]  

  • 6. Doppler evaluation of the effects of pharmacological treatment of portal hypertension.
    Piscaglia F; Gaiani S; Donati G; Masi L; Bolondi L
    Ultrasound Med Biol; 1999 Jul; 25(6):923-32. PubMed ID: 10461720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal hypotensive effects of combined terlipressin and DL-028, a synthetic alpha 1 adrenoceptor antagonist administration on anesthetized portal hypertensive rats.
    Huang YT; Lin LC; Chern JW; Lin HC; Hong CY
    Liver; 1999 Apr; 19(2):129-34. PubMed ID: 10220743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological treatment of portal hypertension.
    Patch D; Burroughs AK
    Prog Liver Dis; 1995; 13():269-92. PubMed ID: 9224506
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating effect of terlipressin on portal pressure in cirrhosis by observing hepatic vein Doppler waveform.
    Hussain Q; Haider S; Solangi NM; Ali L; Liaquat H; Ahmed F; Shahbaz S
    J Pak Med Assoc; 2013 May; 63(5):604-8. PubMed ID: 23757989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of Doppler ultrasonography and hepatic venous pressure gradient in assessing portal hypertension in liver cirrhosis].
    Jeong PH; Baik SK; Choi YJ; Park DH; Kim MY; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Kim ND
    Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):264-70. PubMed ID: 12499783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
    Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ
    Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
    Testro AG; Angus PW
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
    [No Abstract]   [Full Text] [Related]  

  • 13. Science to practice: Noninvasive assessment of portal hypertension--can US aid in the prediction of portal pressure and monitoring of therapy?
    Halpern EJ
    Radiology; 2006 Aug; 240(2):309-10. PubMed ID: 16864661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serendipitous use of terlipressin.
    Ongley D
    Anaesth Intensive Care; 2016 Jan; 44(1):119. PubMed ID: 26673599
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of active gastroesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial.
    García-Compeán D; Blanc P; Bories JM; Michel J; Desprez D; Pageaux GP; David XR; Larrey D; Michel H
    Arch Med Res; 1997; 28(2):241-5. PubMed ID: 9204616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic management of portal hypertension.
    Berzigotti A; Bosch J
    Clin Liver Dis; 2014 May; 18(2):303-17. PubMed ID: 24679496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent variceal bleeding: Doppler US hepatic vein waveform in assessment of severity of portal hypertension and vasoactive drug response.
    Baik SK; Kim JW; Kim HS; Kwon SO; Kim YJ; Park JW; Kim SH; Chang SJ; Lee DK; Han KH; Um SH; Lee SS
    Radiology; 2006 Aug; 240(2):574-80. PubMed ID: 16864678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin: a new therapeutic for calcium-channel blockers overdose.
    Leone M; Charvet A; Delmas A; Albanèse J; Martin C; Boyle WA
    J Crit Care; 2005 Mar; 20(1):114-5. PubMed ID: 16015526
    [No Abstract]   [Full Text] [Related]  

  • 19. Terlipressin or somatostatin for acute variceal hemorrhage.
    Walker S; Kreichgauer HP; Bode JC
    Gastroenterology; 1997 May; 112(5):1777. PubMed ID: 9136866
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.